(0.04%) 5 519.25 points
(0.15%) 39 904 points
(0.07%) 19 765 points
(0.02%) $81.65
(0.50%) $2.83
(-0.25%) $2 338.60
(0.15%) $29.57
(0.62%) $1 008.00
(0.13%) $0.933
(-0.08%) $10.53
(0.02%) $0.788
(-0.85%) $87.25
0.00% $ 0.00860
Live Chart Being Loaded With Signals
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation...
Stats | |
---|---|
Dzisiejszy wolumen | 23 683 |
Średni wolumen | 438 |
Kapitalizacja rynkowa | 192 605 |
EPS | $-0.290 ( Q2 | 2023-08-18 ) |
Następna data zysków | ( $0 ) 2024-07-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | 2014 Kif-sbi It Investment Fund | Sell | 167 600 | Common Stock |
2023-09-27 | Lamond Stephen J | Buy | 2 600 | Common Stock |
2023-09-26 | Lamond Stephen J | Buy | 3 000 | Common Stock |
2023-09-18 | Lamond Stephen J | Buy | 2 500 | Common Stock |
2023-09-15 | Lamond Stephen J | Buy | 11 750 | Common Stock |
INSIDER POWER |
---|
30.34 |
Last 36 transactions |
Buy: 4 014 898 | Sell: 1 875 933 |
Peak Bio, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Peak Bio, Inc. Finanse
Annual | 2022 |
Przychody: | $607 681 |
Zysk brutto: | $607 572 (99.98 %) |
EPS: | $-0.740 |
FY | 2022 |
Przychody: | $607 681 |
Zysk brutto: | $607 572 (99.98 %) |
EPS: | $-0.740 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Peak Bio, Inc.
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company\'s proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej